Affiliation:
1. NATIONAL PIROGOV MEMORIAL MEDICAL UNIVERSITY ,VINNYTSIA, UKRAINE; SCIENTIFIC AND RESEARCH INSTITUTE OF DISABILITY REHABILITATION OF NATIONAL PIROGOV MEMORIAL MEDICAL UNIVERSITY, VINNYTSIA, UKRAINE
2. NATIONAL PIROGOV MEMORIAL MEDICAL UNIVERSITY ,VINNYTSIA, UKRAINE
Abstract
The aim: To assess the level of hepcidin in patients with AS, to determine its connection to the disease and various forms of anemia.
Materials and methods: 118 patients with ankylosing spondylitis were examined and hematological, biochemical, immunologic indicators of the general parameters of
hematopoiesis and ferrokinetics, plasma levels of CRP, IL-6 and hepcidin were determined.
Results: It was found that high levels of hepcidin are found in 25% of patients with AS, 50% are limiting and only 25% are optimal. The serum levels of hepcidin in patients
with AS are independent of the age, sex, and duration of the disease, but are closely associated with the activity (ESR, CRP, IL-6, BASDAI, and ASDAS levels) of the disease. Close
pathogenetic connection of hepcidin with the formation of anemic syndrome was established. Patients with ACD were characterized by the highest levels of hepcidin.
Conclusions: Hepcidin plays an important role in the pathogenesis of ACD in patients with AS and can be used as a diagnostic marker for differential diagnosis.
Reference26 articles.
1. 1. Karlova O.G., Goryaev Yu.A. Prognozirovanie techeniya ankiloziruyushego spondiloartrita [Flow prediction of ankylosing spondyloarthritis]. Current problems of rheumatology 2002, 1. 40-43.( In Russian)
2. 2. Nigmatyanova A.A., Fejshanova L.I., Abdrakipov R.Z., Hasanov RM. Sluchaj tyazhelogo oslozhnennogo ankiloziruyushego spondilita [A case of severe, complicated ankylosing spondylitis]. Practical medicine 2016, 2 (4(96)), 82-84.( In Russian)
3. 3. Shcherbakov G.I., Fomina N.V., Pavlova V.Yu. Vidy anemii i ikh svíyaz’ s aktivnost’yu zabolevaniya u bol’nykh s ankiloziruyushchim spondiloartritom [Types of anemia and their relationship with disease activity in patients with ankylosing spondylitis]. Organization and informatization of healthcare issue. 2016. (S), 386-388.( In Russian)
4. 4. Braun J., Van Der Heijde D., Doyle M.K., Han C. et аl. Improvement in hemoglobin levels in patients with ankylosing spondylitis treated with infliximab. Arthritis Care Res. 2009 61(8), 1032-1036. DOI 10.1002/ art.24865
5. 5. Bulut Y., Tas D.A., Ozturk O.G., Karaogullarindan U. Investigation of iron deficiency anemia in ankylosing spondylitis patients. Ann Rheum Dis. 2017. 6 (1), 921-922. DOI:10.1136/annrheumdis-2017-eular.5913
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献